PT. Penta Valent Tbk (IDX:PEVE)

Market Cap	776.88B
Revenue (ttm)	3.27T
Net Income (ttm)	58.52B
Shares Out	1.77B
EPS (ttm)	33.58
PE Ratio	13.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,746,700
Average Volume	570,795
Open	438.00
Previous Close	440.00
Day's Range	426.00 - 450.00
52-Week Range	226.00 - 500.00
Beta	0.15
RSI	76.50
Earnings Date	Jul 30, 2025

About PT. Penta Valent Tbk

PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. It operates through Pharmaceutical Products and Consumer Goods segments. The company offers medicinal products; over the counter drug products; medical supporting equipment, such as blood pressure meters, body thermometers, and others; reaction materials, such as blood sugar tests, pregnancy tests, or rapid tests for Covid-19, drug tests, etc.; and food supplements comprising minerals and nutrients. It also provides products for beau...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1968
• Employees: 971
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PEVE

Financial Performance

In 2024, PT. Penta Valent Tbk's revenue was 3.01 trillion, an increase of 21.25% compared to the previous year's 2.48 trillion. Earnings were 48.01 billion, an increase of 32.73%.